These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18226597)

  • 1. Mass colorectal cancer screening: methodological quality of practice guidelines is not related to their content validity.
    Watine JC; Bunting PS
    Clin Biochem; 2008 May; 41(7-8):459-66. PubMed ID: 18226597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
    Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
    Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New screening guidelines for colorectal cancer: a practical guide for the primary care physician.
    Allison JE; Potter MB
    Prim Care; 2009 Sep; 36(3):575-602. PubMed ID: 19616156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening.
    McGregor SE; Hilsden RJ; Li FX; Bryant HE; Murray A
    Am J Gastroenterol; 2007 Aug; 102(8):1727-35. PubMed ID: 17437502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer.
    Hakama M; Hoff G; Kronborg O; Påhlman L
    Acta Oncol; 2005; 44(5):425-39. PubMed ID: 16118076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting adequate information across to colorectal cancer screening subjects can be difficult.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Bossuyt PM; Fockens P; Dekker E; Jansen JB
    J Med Screen; 2008; 15(3):149-52. PubMed ID: 18927098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The standardized development method of the Japanese guidelines for cancer screening.
    Hamashima C; Saito H; Nakayama T; Nakayama T; Sobue T
    Jpn J Clin Oncol; 2008 Apr; 38(4):288-95. PubMed ID: 18337318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.
    Rossi F; Sosa JA; Aslanian HR
    J Clin Gastroenterol; 2008; 42(10):1089-94. PubMed ID: 18936643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should you screen--or not? The latest recommendations.
    Campos-Outcalt D
    J Fam Pract; 2008 Jul; 57(7):469-72. PubMed ID: 18625170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of an evidence-based lecture and clinical prompt as methods to improve quality of care in colorectal cancer screening.
    Seres KA; Kirkpatrick AC; Tierney WM
    Am J Gastroenterol; 2009 Feb; 104(2):420-5. PubMed ID: 19190610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of patient-provider communication on colorectal cancer screening.
    Carcaise-Edinboro P; Bradley CJ
    Med Care; 2008 Jul; 46(7):738-45. PubMed ID: 18580394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?
    Vernon SW; Tiro JA; Vojvodic RW; Coan S; Diamond PM; Greisinger A; Fernandez ME
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):758-67. PubMed ID: 18381467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening: how to help patients comply.
    Goldsmith G; Chiaro C
    J Fam Pract; 2008 Jul; 57(7):E2-7. PubMed ID: 18625166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reported cancer screening practices of nephrologists: results from a national survey.
    Wong G; Webster AC; Chapman JR; Craig JC
    Nephrol Dial Transplant; 2009 Jul; 24(7):2136-43. PubMed ID: 19188339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.